FIELD: medicine, pulmonology, pediatrics.
SUBSTANCE: the present innovation deals with treating relapsing nonobstructive bronchitis in children. Due to inhalations it is necessary to introduce Aldecin into bronchi at the dosage of 200-300 mcg/d. The dosage should be decreased by 50 mcg weekly. The period for dosage decrease corresponds to about 3-5 wk. Total duration of therapy course corresponds to about 2-3 mo. The innovation provides efficient removal of bronchial hyperactivity and allergic predisposition of respiratory tract and leads to no relapses during prolonged period of time and proves the necessity to apply glucocorticoids for this category of patients.
EFFECT: higher efficiency of therapy.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
| METHOD FOR PREVENTION OF BRONCHO-OBSTRUCTIVE SYNDROME IN INFANTS AFFECTED BY SECONDARY RESPIRATORY DISEASE | 0 |
|
SU1688881A1 |
| METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
| METHOD FOR TREATMENT OF ASTHMA | 2015 |
|
RU2611406C1 |
| METHOD OF DIAGNOSTICS OF ALLERGIC FORM OF BRONCHIAL ASTHMA IN CHILDREN UNDER 5 | 2016 |
|
RU2647195C1 |
| EFFICIENCY ESTIMATE OF BASELINE ANTIINFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN CHILDREN | 2008 |
|
RU2357259C1 |
| METHOD FOR PREVENTING BRONCHIAL ASTHMA IN CHILDREN WITH RECURRENT LARYNGOTRACHEITIS AND ASSOCIATED ALLERGIC DISEASES | 2020 |
|
RU2757845C1 |
| METHOD OF EVALUATING EFFECTIVENESS BASIC ANTI-INFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN CHILDREN | 2008 |
|
RU2354970C1 |
| METHOD FOR TREATING SPASMODIC COUGH IN PERTUSSIS INFECTION IN CHILDREN | 2019 |
|
RU2724876C1 |
| METHOD FOR PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN SUFFERING RECURRENT OBSTRUCTIVE BRONCHITIS IN INCREASED BIOLOGICAL MEDIUM CONTAMINATION BY HEAVY METALS AND ALDEHYDES | 2011 |
|
RU2459622C1 |
